Article
Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
The Journal of infectious diseases - 1 Nov 1992
Preiksaitis J K, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrrell D L
Abstract excerpt
Epstein-Barr virus (EBV) infection plays a major role in the pathogenesis of posttransplant lymphoproliferative disorder (PTLD). Quantitative oropharyngeal EBV shedding measured by a DNA-DNA dot blot assay and the genotype of isolates determined by a polymerase chain reaction assay were studied in 23 renal and 23 cardiac transplant recipients followed over the first posttransplant year. Five patients developed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
